About Elysium Health
Elysium Health is a company based in New York (United States) founded in 2014. It operates as a Direct-to-Consumer (D2C). Elysium Health has raised $66.1 million across 7 funding rounds from investors including SVB, HHS and Western Technology Investment. Elysium Health offers products and services including Basis, Mosaic, Cofactor, and Index. Elysium Health operates in a competitive market with competitors including Amazentis, DecodeAge, Biote, Timeline and Ponce De Leon Health, among others.
- Headquarter New York, United States
- Stage Minicorn
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Elysium Health
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$66.1 M (USD)
in 7 rounds
-
Latest Funding Round
$283.07 K (USD), Grant
Jun 01, 2023
-
Investors
SVB
& 14 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Elysium Health
Elysium Health offers a comprehensive portfolio of products and services, including Basis, Mosaic, Cofactor, and Index.
Supplement designed for cellular aging support and health.
Product formulated to support skin aging and collagen.
System created to boost collagen and NAD+ levels.
Test developed to measure biological age accurately.
People of Elysium Health
Unlock access to complete
Unlock access to complete
Funding Insights of Elysium Health
Elysium Health has successfully raised a total of $66.1M across 7 strategic funding rounds. The most recent funding activity was a Grant round of $283.07 thousand completed in June 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Elysium Health
Elysium Health has secured backing from 15 investors, including institutional, venture fund, and angel investors. Prominent investors backing the company include SVB, HHS and Western Technology Investment.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital fund focused on multiple sectors
|
Locked | Locked | Locked | |
|
Early-stage startups across multiple sectors are invested in by Sprint.
|
Locked | Locked | Locked | |
|
Venture debt is provided globally across multiple sectors.
|
Locked | Locked | Locked |
Investor details for Elysium Health
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Elysium Health
Investment portfolio details for Elysium Health
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Elysium Health
Detailed financials for Elysium Health
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Elysium Health Comparisons
Peer comparison for Elysium Health
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Elysium Health
Elysium Health operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Amazentis, DecodeAge, Biote, Timeline and Ponce De Leon Health, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developing nutritional products to slow aging and improve quality of life
|
|
| Locked | Locked | Locked |
Online platform offering drugs for longevity and age health
|
|
| Locked | Locked | Locked |
Hormone replacement and pellet therapy services are offered.
|
|
| Locked | Locked | Locked |
Clinically-tested Urolithin A supplements and skincare are developed.
|
|
| Locked | Locked | Locked |
Anti-aging nutraceutical supplements are developed and tested.
|
|
| Locked | Locked | Locked |
Manufacturer of dietary supplements
|
Detailed competitors of Elysium Health
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Elysium Health
Complete news archive for Elysium Health
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Elysium Health
Elysium Health was founded in 2014 and raised its 1st funding round 2 years after it was founded.
Elysium Health is headquartered in New York, United States. It is registered at New York, New York, United States.
Elysium Health is a funded company, having raised a total of $66.1M across 7 funding rounds to date.
Elysium Health is engaged in creating supplements and tests aimed at promoting healthy aging. The company operates in the biotechnology sector, focusing on longevity and cellular health. Solutions such as Basis for NAD support, Mosaic for skin aging, and Index for biological age testing are offered. Research collaborations with institutions like Oxford and Yale are maintained, alongside a commitment to advancing aging science through clinical trials and a scientific advisory board.
Elysium Health offers Basis, Mosaic, Cofactor, and Index.
Elysium Health has 15 investors. Key investors include SVB, HHS, Western Technology Investment, GISEV, and The Venture Collective.
The valuation of Elysium Health is $157M as of Dec 2016.